[1] Shen A, Qiang W, Zhao H, et al.Contemporaneous symptom networks of breast cancer-related upper limb lymphedema: a network analysis[J]. Ann Surg Oncol, 2024, 31(10):6611-6622. DOI:10.1245/s10434-024-15676-0.
[2] 代莉莉,段艳芹. 乳腺癌术后上肢淋巴水肿患者的生活质量和上肢活动度调查[J].护理学报, 2012,19(13):20-22. DOI:10.3969/j.issn.1008-9969.2012.13.006.
[3] Bartels SAL, Donker M, Poncet C, et al.Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial[J]. J Clin Oncol,2023,41(12):2159-2165. DOI:10.1200/JCO.22.01565.
[4] 赵权萍,李凤莲,路潜. 乳腺癌患者术后淋巴水肿相关知识、危险因素及行为状况的研究[J].中华乳腺病杂志(电子版),2019,13(5):296-300. DOI:10.3877/cma.j.issn.1674-0807.2019.05.008.
[5] Harris KB.Hazard analysis critical control point (HACCP) system[M]. United States: John Wiley & Sons, Inc, 2011: 772-785. DOI:10.1002/9781444355321.ch33.
[6] 中国标准化研究院,国家认证认可监督管理委员会注册管理部,中国认证机构国家认可委员会,等. 危害分析与关键控制点(HACCP)体系及其应用指南[Z]. 中华人民共和国国家质量监督检验检疫总局;中国国家标准化管理委员会. 2004:16
[7] Alper BS, Haynes RB.EBHC pyramid 5.0 for accessing preappraised evidence and guidance[J].Evid Based Med,2016,21(4):123-125. DOI:10.1136/ebmed-2016-110447.
[8] Agree Collaboration.Appraisal of Guidelines for Researchand Evaluation in Europe II(AGREEII) instrument[EB/OL]. (2017-12-15)[2023-10-14]. https://www.agreetrust.org/wpcontent/uploads/2017/12/AGREE-II-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf.
[9] 龚雪,宋慧娟,廖少娜,等. 间歇充气加压装置预防围术期深静脉血栓形成的最佳证据总结[J].护理学报,2023,30(16):51-57. DOI:10.16460/j.issn1008-9969.2023.16.051.
[10] The Joanna Briggs Institute(JBI).Critical appraisal tools[EB/OL].(2017-07-15)[2023-12-25].https://joannabriggs.org/crit-ical-appraisal-tools.
[11] 王春青,胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J].护士进修杂志, 2015, 30(11):964-967. DOI:10.16821/j.cnki.hsjx.2015.11.002.
[12] PATH.Strengthening human milk banking: a resource toolkit for establishing and integrating human milk bank programs—a global implementation framework.Version 2.0[EB/OL]. (2019-02-28)[2025-01-13]. https://www.path.org/who-we-are/programs/maternal-newborn-child-health-and-nutrition/strengthening-human-milk-banking-resource-toolkit-2a/.
[13] 钟一亮.潜在危害和显著危害的正确判断[EB/OL]. (2010-10-06)[2024-10-07].https://www.foodmate.net/haccp/2/174.html.
[14] 姚呈,高翔,杨明莹,等. 麻醉护理风险管理培训课程的构建[J].护理学报, 2024, 31(14):33-37. DOI:10.16460/j.issn1008-9969.2024.14.033.
[15] 伍琳,孙艳杰. 德尔菲法简介及在护理学中的应用现状[J].护理研究, 2015, 29(29):3599-3601. DOI:10.3969/j.issn.1009-6493.2015.29.006.
[16] Babak. 外周淋巴水肿的临床特征及诊断[EB/OL]. (2023-07-14)[2024-01-27]. https://www.uptodate.cn/contents/zh-Hans/clinical-features-and-diagnosis-of-peripheral-lymphedema?search=%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9B%B8%E5%85%B3%E6%B7%8B%E5%B7%B4%E6%B0%B4%E8%82%BF&source=search_result&selectedTitle=4%7E150&usage_type=default&display_rank=4.
[17] Babak.乳腺癌相关淋巴水肿[EB/OL]. (2022-04-26)[2024-01-27]. https://www.uptodate.cn/contents/zh-Hans/breast-cancer-associated-lymphedema?search=%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9B%B8%E5%85%B3%E6%B7%8B%E5%B7%B4%E6%B0%B4%E8%82%BF&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1.
[18] Babak. 外周淋巴水肿的临床分期和保守治疗[EB/OL]. (2022-11-16)[2024-01-27]. https://www.uptodate.cn/contents/zh-Hans/clinical-staging-and-conservative-management-of-peripheral-lymphedema?search=%E4%B9%B3%E8%85%BA%E7%99%8C%E7%9B%B8%E5%85%B3%E6%B7%8B%E5%B7%B4%E6%B0%B4%E8%82%BF&source=search_result&selectedTitle=3%7E150&usage_type=default&display_rank=3.
[19] 中国抗癌协会乳腺癌专业委员会,中华医学会肿瘤学分会乳腺肿瘤学组,邵志敏. 中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J].中国癌症杂志,2023,33(12):1092-1186. DOI:10.19401/j.cnki.1007-3639.2023.12.004.
[20] NICE. Early and locally advanced breast cancer: diagnosis and management | guidance[EB/OL]. (2018-07-18)[2024-01-27]. https://www.nice.org.uk/guidance/ng101.
[21] Denlinger CS, Sanft T, Baker KS, et al. Survivorship, Version 1.2023[EB/OL]. (2023-03-24)[2023-11-29]. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1466.
[22] NCI. 淋巴水肿 (PDQ®)[EB/OL]. (2023-09-13)[2024-01-13]. https://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema/lymphedema-hp-pdq.
[23] Kitamura K, Iwase S, Komoike Y, et al.Evidence-based practice guideline for the management of lymphedema proposed by the Japanese Lymphedema Society[J]. Lymphat Res Biol,2022,20(5):539-547. DOI:10.1089/lrb.2021.0032.
[24] Davies C, Levenhagen K, Ryans K, et al.Interventions for breast cancer-related lymphedema:clinical practice guideline from the Academy of Oncologic Physical Therapy of APTA[J].Phys Ther,2020,100(7):1163-1179. DOI:10.1093/ptj/pzaa087.
[25] Armer J, Ostby P, Ginex P, et al.ONS Guidelines^TM for cancer treatment-related lymphedema[J].Oncol Nurs Forum,2020,47(5):518-538. DOI:10.1188/20.ONF.518-538.
[26] Levenhagen K, Davies C, Perdomo M, et al.Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the oncology section of the American Physical Therapy Association[J].Phys Ther,2017,97(7):729-745. DOI:10.1093/ptj/pzx050.
[27] NICE. Advanced breast cancer: diagnosis and treatment[EB/OL]. (2017-08-16)[2024-01-27]. https://www.nice.org.uk/guidance/cg81.
[28] Damstra RJ, Halk AB, Dutch Working Group on Lymphedema. The Dutch lymphedema guidelines based on the International Classification of Functioning, Disability, and Health and the chronic care model[J].J Vasc Surg Venous Lymphat Disord, 2017, 5(5):756-765. DOI:10.1016/j.jvsv.2017.04.012.
[29] Lurie F, Malgor RD, Carman T, et al.The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatment[J].Phlebology,2022,37(4):252-266. DOI:10.1177/02683555211053532.
[30] Martínez-Jaimez P, Fuster Linares P, Piller N, et al.Multidisciplinary preventive intervention for breast cancer-related lymphedema: an international consensus[J].Eur J Cancer Care (Engl),2022,31(6):e13704.DOI:10.1111/ecc.13704.
[31] Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology[J].Lymphology,2020,53(1):3-19.
[32] McLaughlin SA, Staley AC, Vicini F, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS Panel: part 1: definitions, assessments, education, and future directions[J].Ann Surg Oncol,2017,24(10):2818-2826. DOI:10.1245/s10434-017-5982-4.
[33] McLaughlin SA, DeSnyder SM, Klimberg S, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema, recommendations from an expert panel: part 2: preventive and therapeutic options[J].Ann Surg Oncol,2017,24(10):2827-2835. DOI:10.1245/s10434-017-5964-6.
[34] Perdomo M, Davies C, Levenhagen K, et al.Patient education for breast cancer-related lymphedema: a systematic review[J].J Cancer Surviv,2023,17(2):384-398. DOI:10.1007/s11764-022-01262-4.
[35] Hayes SC, Singh B, Reul-Hirche H, et al.The effect of exercise for the prevention and treatment of cancer-related lymphedema: a systematic review with Meta-analysis[J].Med Sci Sports Exerc,2022,54(8):1389-1399. DOI:10.1249/MSS.0000000000002918.
[36] Rafn BS, Christensen J, Larsen A, Bloomquist K.Prospective surveillance for breast cancer-related arm lymphedema: a systematic review and Meta-analysis[J]. J Clin Oncol,2022,40(9):1009-1026. DOI:10.1200/JCO.21.01681.
[37] 聂立婷,赵妹,殷秀敏,等. 徒手淋巴引流在乳腺癌术后淋巴水肿中应用效果的Meta分析[J].中国康复,2020,35(5):256-261. DOI:10.3870/zgkf.2020.05.009.
[38] 杨璇,张海林,刘玉,等. 徒手淋巴引流对乳腺癌相关淋巴水肿预防及治疗效果的Meta分析[J].中国护理管理,2019,19(6):824-829.DOI:10.3969/j.issn.1672-1756.2019.06.006.
[39] Olsson Möller U, Beck I, Rydén L, et al.A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews[J].BMC Cancer, 2019,19(1):472.DOI:10.1186/s12885-019-5648-7.
[40] 李惠萍, 杨娅娟, 苏丹, 等. 不同预防行为对乳腺癌术后淋巴水肿的预防效果Meta分析[J].现代预防医学,2018,45(5):949-960.
[41] 王惠雪, 李惠萍, 杨娅娟, 等. 空气波压力治疗仪在预防及治疗乳腺癌术后淋巴水肿效果Meta分析[J].中华肿瘤防治杂志,2017,24(11):773-778.
[42] Baumann FT, Reike A, Hallek M, et al.Does exercise have a preventive effect on secondary lymphedema in breast cancer patients following local treatment? A systematic review[J].Breast Care (Basel),2018,13(5):380-385. DOI:10.1159/000487428.
[43] Hidding JT, Viehoff PB, Beurskens CH, et al.Measurement properties of instruments for measuring of lymphedema: systematic review[J]. Phys Ther,2016,96(12):1965-1981. DOI:10.2522/ptj.20150412.
[44] Wang L, Shi YX, Wang TT, et al.Breast cancer-related lymphoedema and resistance exercise: an evidence-based review of guidelines, consensus statements and systematic reviews[J].J Clin Nurs,2023,32(9-10):2208-2227. DOI:10.1111/jocn.16437.
[45] Johal J. Lymphedema (breast cancer): resistance training[EB/OL]. (2023-03-31)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI11997.
[46] Johal J. Breast cancer: lymphedema management[EB/OL]. (2023-03-27)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI379.
[47] Magtoto EN, Ishaque S. Lymphedema: skin care[EB/OL]. (2023-07-12)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI14183.
[48] Whitehorn A, Zaccagnini M. Breast cancer-related lymphedema: risk factors[EB/OL]. (2023-05-24)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI23876.
[49] Ruiz N. Breast cancer: care provided by specialist breast cancer nurses[EB/OL]. (2023-06-19)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI119926.
[50] Moola S. Lymphedema: self-reported assessment[EB/OL]. (2021-03-25)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI11560.
[51] Moola S.Lymphedema: objective assessment using circumference measurement[EB/OL]. (2021-11-12)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI12020.
[52] Pamaiahgari P. Lymphedema: objective assessment using volumetry[EB/OL]. (2021-10-08)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI11871.
[53] Sharma L. Lymphedema in breast cancer: manual lymphatic drainage[EB/OL]. (2021-02-20)[2023-12-19]. https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI12921.
[54] Edwards D. Breast-cancer related lymphedema: accuracy of quality of life measures[EB/OL]. (2021-04-30)[2023-12-19].https://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=jbi&AN=JBI22187.
[55] 黄福南. 危害分析关键控制点(HACCP)[J].食品与发酵工业,2002,28(2):75-79. DOI:10.3321/j.issn:0253-990X.2002.02.018.
[56] Shen A, Wei X, Zhu F, et al.Risk prediction models for breast cancer-related lymphedema: a systematic review and meta-analysis[J].Eur J Oncol Nurs,2023,64:102326. DOI: 10.1016/j.ejon.2023.102326.
[57] Chan KS, Zeng D, Leung JHT, et al.Measuring upper limb function and patient reported outcomes after major breast cancer surgery: a pilot study in an Asian cohort[J]. BMC Surg,2020,20(1):108. DOI: 10.1186/s12893-020-00773-0.
[58] 阮祥梅, 贾杰. 乳腺癌术后肩关节功能障碍康复的研究进展[J].中华物理医学与康复杂志,2018,40(3):230-233. DOI:10.3760/cma.j.issn.0254-1424.2018.03.019.